Literature DB >> 25381961

Conversion between mini-mental state examination, montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson's disease.

Inger van Steenoven1, Dag Aarsland, Howard Hurtig, Alice Chen-Plotkin, John E Duda, Jacqueline Rick, Lama M Chahine, Nabila Dahodwala, John Q Trojanowski, David R Roalf, Paul J Moberg, Daniel Weintraub.   

Abstract

Cognitive impairment is one of the earliest, most common, and most disabling non-motor symptoms in Parkinson's disease (PD). Thus, routine screening of global cognitive abilities is important for the optimal management of PD patients. Few global cognitive screening instruments have been developed for or validated in PD patients. The Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), and Dementia Rating Scale-2 (DRS-2) have been used extensively for cognitive screening in both clinical and research settings. Determining how to convert the scores between instruments would facilitate the longitudinal assessment of cognition in clinical settings and the comparison and synthesis of cognitive data in multicenter and longitudinal cohort studies. The primary aim of this study was to apply a simple and reliable algorithm for the conversion of MoCA to MMSE scores in PD patients. A secondary aim was to apply this algorithm for the conversion of DRS-2 to both MMSE and MoCA scores. The cognitive performance of a convenience sample of 360 patients with idiopathic PD was assessed by at least two of these cognitive screening instruments. We then developed conversion scores between the MMSE, MoCA, and DRS-2 using equipercentile equating and log-linear smoothing. The conversion score tables reported here enable direct and easy comparison of three routinely used cognitive screening assessments in PD patients.
© 2014 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Dementia Rating Scale-2; Mini-Mental State Examination; Montreal Cognitive Assessment; Parkinson's disease; cognitive screening scales

Mesh:

Year:  2014        PMID: 25381961      PMCID: PMC4371590          DOI: 10.1002/mds.26062

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  38 in total

1.  Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score.

Authors:  Sarra Nazem; Andrew D Siderowf; John E Duda; Tom Ten Have; Amy Colcher; Stacy S Horn; Paul J Moberg; Jayne R Wilkinson; Howard I Hurtig; Matthew B Stern; Daniel Weintraub
Journal:  J Am Geriatr Soc       Date:  2008-12-10       Impact factor: 5.562

2.  Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD).

Authors:  Oliver Riedel; Jens Klotsche; Annika Spottke; Günther Deuschl; Hans Förstl; Fritz Henn; Isabella Heuser; Wolfgang Oertel; Heinz Reichmann; Peter Riederer; Claudia Trenkwalder; Richard Dodel; Hans-Ulrich Wittchen
Journal:  J Neurol       Date:  2008-01-22       Impact factor: 4.849

Review 3.  Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment.

Authors:  Jaime Kulisevsky; Javier Pagonabarraga
Journal:  Mov Disord       Date:  2009-06-15       Impact factor: 10.338

4.  Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial.

Authors:  Connie Marras; Michael P McDermott; Paula A Rochon; Caroline M Tanner; Gary Naglie; Anthony E Lang
Journal:  Mov Disord       Date:  2008-04-15       Impact factor: 10.338

Review 5.  Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force.

Authors:  Bruno Dubois; David Burn; Christopher Goetz; Dag Aarsland; Richard G Brown; Gerald A Broe; Dennis Dickson; Charles Duyckaerts; Jefferey Cummings; Serge Gauthier; Amos Korczyn; Andrew Lees; Richard Levy; Irene Litvan; Yoshikuni Mizuno; Ian G McKeith; C Warren Olanow; Werner Poewe; Cristina Sampaio; Eduardo Tolosa; Murat Emre
Journal:  Mov Disord       Date:  2007-12       Impact factor: 10.338

6.  Telephone interview for cognitive status: Creating a crosswalk with the Mini-Mental State Examination.

Authors:  Tamara G Fong; Michael A Fearing; Richard N Jones; Peilin Shi; Edward R Marcantonio; James L Rudolph; Frances M Yang; Dan K Kiely; Sharon K Inouye
Journal:  Alzheimers Dement       Date:  2009-07-31       Impact factor: 21.566

7.  Cut-off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease.

Authors:  Gisela Llebaria; Javier Pagonabarraga; Jaime Kulisevsky; Carmen García-Sánchez; Berta Pascual-Sedano; Alexandre Gironell; Mercè Martínez-Corral
Journal:  Mov Disord       Date:  2008-08-15       Impact factor: 10.338

8.  The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years.

Authors:  Mariese A Hely; Wayne G J Reid; Michael A Adena; Glenda M Halliday; John G L Morris
Journal:  Mov Disord       Date:  2008-04-30       Impact factor: 10.338

9.  Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.

Authors:  D Aarsland; K Brønnick; J P Larsen; O B Tysnes; G Alves
Journal:  Neurology       Date:  2008-11-19       Impact factor: 9.910

Review 10.  Clinical diagnostic criteria for dementia associated with Parkinson's disease.

Authors:  Murat Emre; Dag Aarsland; Richard Brown; David J Burn; Charles Duyckaerts; Yoshikino Mizuno; Gerald Anthony Broe; Jeffrey Cummings; Dennis W Dickson; Serge Gauthier; Jennifer Goldman; Christopher Goetz; Amos Korczyn; Andrew Lees; Richard Levy; Irene Litvan; Ian McKeith; Warren Olanow; Werner Poewe; Niall Quinn; Christina Sampaio; Eduardo Tolosa; Bruno Dubois
Journal:  Mov Disord       Date:  2007-09-15       Impact factor: 10.338

View more
  30 in total

1.  Computerized assessment of goal-directed behavior in Parkinson's disease.

Authors:  Whitney Fitts; Lauren Massimo; Nicholas Lim; Murray Grossman; Nabila Dahodwala
Journal:  J Clin Exp Neuropsychol       Date:  2016-06-07       Impact factor: 2.475

2.  Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts.

Authors:  Ganqiang Liu; Joseph J Locascio; Jean-Christophe Corvol; Brendon Boot; Zhixiang Liao; Kara Page; Daly Franco; Kyle Burke; Iris E Jansen; Ana Trisini-Lipsanopoulos; Sophie Winder-Rhodes; Caroline M Tanner; Anthony E Lang; Shirley Eberly; Alexis Elbaz; Alexis Brice; Graziella Mangone; Bernard Ravina; Ira Shoulson; Florence Cormier-Dequaire; Peter Heutink; Jacobus J van Hilten; Roger A Barker; Caroline H Williams-Gray; Johan Marinus; Clemens R Scherzer
Journal:  Lancet Neurol       Date:  2017-06-16       Impact factor: 44.182

3.  MMSE and MoCA in Parkinson's disease and dementia with Lewy bodies: a multicenter 1-year follow-up study.

Authors:  Roberta Biundo; L Weis; S Bostantjopoulou; E Stefanova; C Falup-Pecurariu; M G Kramberger; G J Geurtsen; A Antonini; D Weintraub; D Aarsland
Journal:  J Neural Transm (Vienna)       Date:  2016-02-06       Impact factor: 3.575

4.  Bridging cognitive screening tests in neurologic disorders: A crosswalk between the short Montreal Cognitive Assessment and Mini-Mental State Examination.

Authors:  David R Roalf; Tyler M Moore; Dawn Mechanic-Hamilton; David A Wolk; Steven E Arnold; Daniel A Weintraub; Paul J Moberg
Journal:  Alzheimers Dement       Date:  2017-02-24       Impact factor: 21.566

5.  Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort.

Authors:  Inger van Steenoven; Dag Aarsland; Daniel Weintraub; Elisabet Londos; Frédéric Blanc; Wiesje M van der Flier; Charlotte E Teunissen; Brit Mollenhauer; Tormod Fladby; Milica G Kramberger; Laura Bonanni; Afina W Lemstra
Journal:  J Alzheimers Dis       Date:  2016-08-18       Impact factor: 4.472

6.  [Conversions of cognitive screenings : Mini-Mental State Examination vs. Montreal Cognitive Assessment vs. DemTect].

Authors:  J F Scheffels; H Kräling; E Kalbe; J Kessler
Journal:  Nervenarzt       Date:  2018-12       Impact factor: 1.214

7.  Sex differences in Parkinson's disease presentation and progression.

Authors:  Danielle S Abraham; Ann L Gruber-Baldini; Laurence S Magder; Patrick F McArdle; Sarah E Tom; Erik Barr; Katrina Schrader; Lisa M Shulman
Journal:  Parkinsonism Relat Disord       Date:  2019-10-23       Impact factor: 4.891

8.  Defining and validating a short form Montreal Cognitive Assessment (s-MoCA) for use in neurodegenerative disease.

Authors:  David R Roalf; Tyler M Moore; David A Wolk; Steven E Arnold; Dawn Mechanic-Hamilton; Jacqueline Rick; Sushila Kabadi; Kosha Ruparel; Alice S Chen-Plotkin; Lama M Chahine; Nabila A Dahodwala; John E Duda; Daniel A Weintraub; Paul J Moberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  2016-04-12       Impact factor: 10.154

Review 9.  The Neuropsychiatric and Motor Profile of GBA-Associated Parkinson's Disease: A Review.

Authors:  Gian Pal; Erin Robertson; Joan O'Keefe; Deborah Hall
Journal:  Mov Disord Clin Pract       Date:  2015-09-16

10.  Converting from the Montreal Cognitive Assessment to the Mini-Mental State Examination-2.

Authors:  Hwabeen Yang; Daehyuk Yim; Moon Ho Park
Journal:  PLoS One       Date:  2021-07-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.